These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1301664)

  • 21. [The effect of different Yersinia pestis antigens on the cellular link in immunity].
    Isupov IV; Nazarova LS; Pavlova LP; Gor'kova AV; Revazova ES; Dushkin VA; Zadumina SIu; Surikov NN; Taranenko TM; Dzhaparidze MN
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Sep; (9):85-9. PubMed ID: 2256408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The isolation and characteristics of variant plague microbes not producing the capsular antigen].
    Gvozdenko NA; Ryzhkov VIu; Pavlovich NV
    Mikrobiol Zh (1978); 1990; 52(6):13-7. PubMed ID: 2097497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of immune modulation on immunogenic and protective activity of a live plague vaccine].
    Karal'nik BV; Ponomareva TS; Deriabin PN; Denisova TG; Mel'nikova NN; Tugambaev TI; Atshabar BB; Zakarian SB
    Zh Mikrobiol Epidemiol Immunobiol; 2014; (6):108-12. PubMed ID: 25816525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lectin of Yersinia pestis vaccine strain EV and its immunological properties].
    Tikhomirova EI; Zadnova SP; Volokh OA; Karpunina LV; Shcherbakov AA
    Zh Mikrobiol Epidemiol Immunobiol; 2003; (1):51-5. PubMed ID: 12630354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Changes in the ultrastructure of P. pestis in the bodies of guinea pigs].
    Kenig EE; Sageeva OF; Shakhlamov VA
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Dec; 45(12):8-11. PubMed ID: 5733867
    [No Abstract]   [Full Text] [Related]  

  • 26. Construction of defined F1 negative mutants of virulent Yersinia pestis.
    Worsham PL; Stein MP; Welkos SL
    Contrib Microbiol Immunol; 1995; 13():325-8. PubMed ID: 8833864
    [No Abstract]   [Full Text] [Related]  

  • 27. [Results of a trial of a plague monoclonal antibody erythrocyte diagnostic agent].
    Sergiev VP; Fedorov IuM; Levi MI; Kanatov IuV
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Nov; (11):82-7. PubMed ID: 2936047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs.
    Feodorova VA; Pan'kina LN; Savostina EP; Sayapina LV; Motin VL; Dentovskaya SV; Shaikhutdinova RZ; Ivanov SA; Lindner B; Kondakova AN; Bystrova OV; Kocharova NA; Senchenkova SN; Holst O; Pier GB; Knirel YA; Anisimov AP
    Vaccine; 2007 Nov; 25(44):7620-8. PubMed ID: 17913308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The mutagenic effect of polymorphonuclear leukocytes on Yersinia pestis].
    Atchabarov BB; Isin ZhM; Suleĭmenov BM
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Apr; (4):10-4. PubMed ID: 2735164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The characterization of the protective properties of antiplague preparations by using the index of macrophage subpopulation redistribution].
    Vasil'eva GI; Tkachenko LN; Verkina LM; Doroshenko EP
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):94-6. PubMed ID: 7879567
    [No Abstract]   [Full Text] [Related]  

  • 31. [Apoptosis of phagocytes as one of the probable mechanisms of the pathogenetic action of Yersinia pestis "mouse" toxin].
    Vasil'eva GI; Kiseleva AK; Mishan'kin MB; Kozlovskiĭ VN; Mishan'kin BN
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (2):49-52. PubMed ID: 15881939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Morphofunctional evaluation of the state of cells of APUD-system biomodel during anti-plague vaccine process].
    Bugorkova SA; Kutyreva VV
    Zh Mikrobiol Epidemiol Immunobiol; 2013; (4):49-55. PubMed ID: 24341215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of domestic animals in the epidemiology of plague. 3. Experimental infection of swine.
    Marshall JD; Harrison DN; Murr JA; Cavanaugh DC
    J Infect Dis; 1972 May; 125(5):556-9. PubMed ID: 5023646
    [No Abstract]   [Full Text] [Related]  

  • 34. Novel CTL epitopes identified through a Y. pestis proteome-wide analysis in the search for vaccine candidates against plague.
    Zvi A; Rotem S; Zauberman A; Elia U; Aftalion M; Bar-Haim E; Mamroud E; Cohen O
    Vaccine; 2017 Oct; 35(44):5995-6006. PubMed ID: 28606812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Experimental protective of fraction I of the plague microbe].
    Pautov VN; Chicherin IuV; Evstigneev VI; Byvalov AA; Kedrov OA
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Oct; (10):37-42. PubMed ID: 116458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Yersinia pestis requires the 2-component regulatory system OmpR-EnvZ to resist innate immunity during the early and late stages of plague.
    Reboul A; Lemaître N; Titecat M; Merchez M; Deloison G; Ricard I; Pradel E; Marceau M; Sebbane F
    J Infect Dis; 2014 Nov; 210(9):1367-75. PubMed ID: 24813471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Characteristics of the capsular antigen preparations isolated from a broth culture of Yersinia pestis strain EV].
    Veĭnblat VI; Titenko MM; Verenkov MS; Men'shov PI; Kormilitsyn AV
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Apr; (4):19-24. PubMed ID: 3925663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virulent non-capsulate Yersinia pestis variants constructed by insertion mutagenesis.
    Drozdov IG; Anisimov AP; Samoilova SV; Yezhov IN; Yeremin SA; Karlyshev AV; Krasilnikova VM; Kravchenko VI
    J Med Microbiol; 1995 Apr; 42(4):264-8. PubMed ID: 7707334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of hypoxic state in experimental animals induced by Yersinia pestis antigens].
    Kagramanov VS; Aseeva LE; Goncharov EK
    Zh Mikrobiol Epidemiol Immunobiol; 2002; (5):65-7. PubMed ID: 12525005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The comparative characteristics of preparations of Yersinia pestis capsular antigen F1 obtained from producer strains with different lipopolysaccharide structures].
    Gremiakova TA; Stepanshina VN; Negriĭ VF; Korobova OV; Anisimov GA; Apollonin AV; Likhoded VG
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (3):10-4. PubMed ID: 7941851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.